Off-pump Coronary Bypass Surgery in Patients With Low Ejection Fraction: Is There a Long-Term Survival Advantage?

Hagen Gorki1, Nirav C Patel, Georgia Panagopoulos

  • 1From the *Department of Cardiothoracic Surgery, Lenox Hill Hospital, New York, NY USA; †Department of Cardiac Surgery, Zentralklinik Bad Berka, Bad Berka, Germany; and ‡Department of Research, Lenox Hill Hospital, New York, NY USA.

Insights

Off-pump coronary artery bypass surgery (OPCAB) offers better short-term outcomes for patients with low ejection fraction. However, long-term survival after OPCAB is comparable to on-pump coronary artery bypass surgery (ONCAB).

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Minimally Invasive Cardiac Surgery

Background:

  • Patients with low ejection fraction (≤30%) represent a high-risk group for coronary artery bypass surgery.
  • Off-pump coronary artery bypass surgery (OPCAB) aims to reduce surgical trauma compared to traditional on-pump coronary artery bypass surgery (ONCAB).

Purpose of the Study:

  • To investigate the long-term survival rates of patients with low ejection fraction undergoing OPCAB.
  • To compare the outcomes of OPCAB with historical ONCAB data and literature data for percutaneous coronary intervention and OPCAB.

Main Methods:

  • A cohort of 346 patients with ejection fraction ≤30% who underwent isolated OPCAB was analyzed.
  • Propensity score matching was used to compare OPCAB patients with a historical ONCAB group.
  • Outcomes were also compared with available literature data for percutaneous coronary intervention and OPCAB in high-risk populations.

Main Results:

  • OPCAB demonstrated significantly better 30-day survival, shorter hospital stays, and fewer in-hospital complications due to its lower invasiveness.
  • Incomplete revascularization, particularly of posterior and lateral heart territories, was associated with increased 1-year mortality.
  • Eight-year survival probability was 50.1% for OPCAB versus 49.7% for ONCAB, with no significant long-term survival advantage observed.

Conclusions:

  • Off-pump coronary artery bypass surgery (OPCAB) is a feasible alternative for patients with low ejection fraction.
  • Currently, OPCAB does not show a demonstrable long-term survival advantage over on-pump coronary artery bypass surgery (ONCAB) in this high-risk patient group.
Abstract

Related Concept Videos